TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: 5-year risk for stroke or MI
Endpoint domain: Mortality/survival
Primary endpoint: risk for fracture
Endpoint domain: Adverse events/effects
Primary endpoint: Fewer hypoglycaemic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean percentage decrease in systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean percentage decrease in diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in serum levels of hs-CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in serum levels of IL-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Successful treatment rate with hydrocortisone ointment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in EASI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients achieving LDL-C levels <1.8 mmol/l
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: increased bleeding risk with warfarin
Endpoint domain: Adverse events/effects
Primary endpoint: High-density lipoprotein and low-density lipoprotein profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Triglyceride and total cholesterol profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of enteral feeding intolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: occurrence rate of serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Cooling efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in early diastolic mitral annular velocity (e', cm/s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in response to interventions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fat-Free Mass (FFM) prediction accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: short-term fetal side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Mean urine leukocyte count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Oxygenation improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in AaDO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quit rates at 30-day follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak-stimulated LH suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: acute and late side-effects
Endpoint domain: Adverse events/effects
Primary endpoint: Insomnia symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oversleeping
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Undersleeping
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean imprecision in predicting the end of the operative day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Throughput (cases scheduled)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite rate of adverse 30-day events
Endpoint domain: Adverse events/effects
Primary endpoint: ISI-composite
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ISI-HOMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hemoglobin A1c (HbA1c) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of grade 2 hypoglycemia
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of life improvements
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: High-order aberration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cure rate after 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Contamination rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: ANC recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: client discomfort
Endpoint domain: Adverse events/effects
Primary endpoint: C-D III-V complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: weight regain percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroconversion to poliovirus types 1, 2, and 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Priming immune response to poliovirus types 1, 2, and 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: serum beta2-microglobulin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean distress scores for children
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mean distress scores for parents
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of cholangitis or septicaemia
Endpoint domain: Adverse events/effects
Primary endpoint: Positive blood cultures
Endpoint domain: Adverse events/effects
Primary endpoint: Probability of remission (CR or PR)
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in proteinuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of time to all-cause mortality or cardiovascular hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: 6 month change from baseline in the 6 min walk test distance (6MWTD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Global Assessment (PGA) at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: non-fatal myocardial infarction and fatal CHD events
Endpoint domain: Mortality/survival
Primary endpoint: days of antibiotic use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: neutrophil recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: lipid utilization rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: carbohydrate utilization rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: circulating metabolic markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: increased breastfeeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in facial wrinkles and elasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Type I procollagen mRNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in UV-induced thymine dimer staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average concentrations of maxacalcitol in the stratum corneum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: mean fluorescent intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD4+ T-lymphocytes count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CD8+ T-lymphocytes count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of pneumonitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Inappropriate drug use
Endpoint domain: Adverse events/effects
Primary endpoint: Scores of TCM symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Scores of TCSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Glycated haemoglobin reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: no or minimal disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvements in HRQoL scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Overall success rate of dental treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful completion of dental treatment in 3 sessions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum FEV(1) achieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: median time to achieve 80% of personal best FEV(1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: hepatic enzymes activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intensity of statin adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of amputation/bone resection
Endpoint domain: Adverse events/effects
Primary endpoint: Normalized plasma triacylglycerols
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Normalized plasma high-density lipoprotein cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Affective elements in technical responses
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Increase in blood ALP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Decrease in serum calcium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Average linear growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 26-week CO-confirmed abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of patients achieving total control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life (QOL) as reported on the Functional Living Index‐Emesis questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Volume of new bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Density of new bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: genital arousal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alveolar bone crest absorption and length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: toothbrushing behaviour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mean YMRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in peak VO(2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain during surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Anesthesia-related difficulties
Endpoint domain: Adverse events/effects
Primary endpoint: maxillary arch length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: transversal dimension between the upper first molars
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mandibular arch length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: transversal dimension between the lower first molars
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Febrile infections incidence
Endpoint domain: Adverse events/effects
Primary endpoint: seizure frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: feasibility of energy conservation programme
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Extrusion of the maxillary molars
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in mandibular plane angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of episiotomies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of perineal tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Central nervous system side-effects
Endpoint domain: Adverse events/effects
Primary endpoint: Gastro-intestinal side-effects
Endpoint domain: Adverse events/effects
Primary endpoint: Median CD4 cell count increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Median p24 antigen concentration decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric mean titer of HIV in plasma decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Post-Void Residual Volume (PVRV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean pain score during endometrial biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lung function indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Sputum TCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Absence of pain during subarachnoid puncture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of excessive sedation
Endpoint domain: Adverse events/effects
Primary endpoint: postoperative IOP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: necessity for glaucoma medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to GI tract recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Development of lymphedema
Endpoint domain: Mortality/survival
Primary endpoint: Symptom scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: attendance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Transcutaneous oxygen pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of major amputation
Endpoint domain: Mortality/survival
Primary endpoint: Development of HIT
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative PCA morphine intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimated Energy Expenditure (EEPA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean frequency of diarrhea days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: days with diarrhea per total feeding days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: mean diarrhea score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Concentration of hepcidin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Blood IL-6 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: mean dAUC for MPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to Cmax (tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mood lowering effect of TD
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Serotonin‐associated plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean rib fracture pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early return to normal activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Crestal bone preservation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GMFM‐88 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day length of stay (LOS)
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Rate of ERCPs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: safety and effectiveness of transcatheter MV repair
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean CTT reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lifetime risk (LTR) for stroke
Endpoint domain: Mortality/survival
Primary endpoint: Lifetime risk (LTR) for cerebral infarction
Endpoint domain: Mortality/survival
Primary endpoint: Lifetime risk (LTR) for intracerebral hemorrhage
Endpoint domain: Mortality/survival
Primary endpoint: Vaginal health improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sexual function improvement
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Biomarkers related to oxidative stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cases of symptomatic CVS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KPS scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: GOS scores of 4 and 5
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: catheterization time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Induction of allergen tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: degree of erosion on root canal walls
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ease of intubation (visual analog scale score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cormack-Lehane Grade I or II glottic view incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence or severity of neurologic complications
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of DE symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of DE symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain score at the end of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage increase in end-diastolic perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: percentage increase in regional ejection fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: percentage increase in regional wall thickening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants randomized
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Composite primary end point of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke
Endpoint domain: Mortality/survival
Primary endpoint: color
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: parent-child reading improvement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cardiorespiratory fitness (maximal exercise oxygen uptake, V˙O2peak)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral blood flow (CBF) in the PFC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: FAB scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: periodontal disease score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: premature rupture of membranes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: D-dimer levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Coagulation activity outcomes
Primary endpoint: F1 + 2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Coagulation activity outcomes
Primary endpoint: Hepatic triglyceride content (HTGC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total WOMAC score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait ability score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of A1C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Depression symptoms improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pathological constitution improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ApoCIII levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: VLDL diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 15D scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: self-report HHS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status